The Medicines Control of Zimbabwe (MCZ) has opened applications for cannabis and hemp producers, manufacturers, importers, exporters and retail pharmacists to sell cannabis-based medical products
The MCZ released regulations that will guide investments in the sector as the country, sanctioned by the West, banks on the growing global cannabis market.
The country, which is one of the leading producers of tobacco in the world, is considering a shift from the golden leaf to cannabis as the global tobacco ban lobby continues to gather momentum.
President Emmerson Mnangagwa May this year commissioned $27 million medical cannabis farm and processing plant owned by Swiss Bioceuticals Limited.
At the time, he revealed that 57 entities had been issued cannabis production licenses and 15 of them were already operational.
Advocates of the use of cannabis-based products say they can be used to treat chronic pain, inflammation, migraines, epilepsy, depression and anxiety, among other ailments.
The use of cannabis for recreational purposes remains banned in Zimbabwe and thousands of people have been arrested this year for illegally cultivating the crop as the country tries to fight rampant drug abuse among young people.